ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BMK Benchmark Holdings Plc

43.50
0.25 (0.58%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings Plc LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.25 0.58% 43.50 43.00 43.50 42.90 42.40 42.90 334,274 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 169.74M -23.15M -0.0313 -13.71 317.18M

Benchmark Holdings PLC Result of AGM (9122S)

14/03/2019 12:21pm

UK Regulatory


Benchmark (LSE:BMK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Benchmark Charts.

TIDMBMK

RNS Number : 9122S

Benchmark Holdings PLC

14 March 2019

14 March 2019

Benchmark Holdings plc

("Benchmark" or the "Company" or the "Group")

Result of AGM

Benchmark Holdings plc, the aquaculture health, nutrition and genetics business, announces that at the Company's Annual General Meeting, held at 12pm today, all resolutions were duly passed.

ENDS-

 
Benchmark Holdings plc                           Tel: 020 3915 1236 
Malcolm Pye, CEO 
Ivonne Cantu, Investor Relations Director 
Rachel Aninakwah, Communications 
 
Numis                                            Tel: 020 7260 1000 
Michael Meade / Freddie Barnfield (NOMAD) 
James Black (Corporate Broking) 
 
MHP 
Katie Hunt / Reg Hoare /Alistair de Kare-Silver  Tel: 020 3128 8742 
                                                  benchmark@mhpc.com 
 

Notes to Editors:

Benchmark's mission is to drive sustainability in food production. We are a leading provider of aquaculture solutions in genetics, health and specialist nutrition. Our focus is on developing innovative products that help fish and shrimp producers improve their sustainability and profitability by improving yield, quality, health and welfare. Our main products are salmon eggs with superior genetic traits, specialist nutrition products for shrimp and fish, and health treatments including a sea lice treatment for salmon. We serve all the major aquaculture markets around the world and have leading market positions. Benchmark operates in 27 countries, employs 1,066 people and reported revenues of GBP150.5m in FY 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGUSAURKKAOAAR

(END) Dow Jones Newswires

March 14, 2019 08:21 ET (12:21 GMT)

1 Year Benchmark Chart

1 Year Benchmark Chart

1 Month Benchmark Chart

1 Month Benchmark Chart

Your Recent History

Delayed Upgrade Clock